# Intravascular Molecular-Structural Imaging of Coronary Stent Pathobiology > **NIH NIH K08** · BETH ISRAEL DEACONESS MEDICAL CENTER · 2020 · $164,376 ## Abstract PROJECT SUMMARY Dr. Eric Osborn is an early career faculty member at Beth Israel Deaconess Medical Center (BIDMC) and Massachusetts General Hospital (MGH), and an Instructor in Medicine at Harvard Medical School, Boston, Massachusetts. He is a graduate of the MD-PhD program at Harvard Medical School and Massachusetts Institute of Technology, and has completed clinical training in medicine and subspecialty training in cardiology at BIDMC. His goal is to become an independent physician-scientist, using innovative molecular imaging approaches to investigate the key in vivo pathobiology underlying atherothrombosis and coronary stent healing. Dr. Osborn is fully committed to a career in academic cardiology, and is pursuing an NIH K08 Career Development Award in the laboratory of his mentor, Dr. Farouc Jaffer (Cardiovascular Research Center, MGH), to gain the additional expertise necessary to develop into a successful independent investigator. Dr. Osborn's career development plan leverages the resources of a world-class environment at two leading academic institutions, BIDMC and MGH, to acquire essential new skills that will position him to answer important questions in cardiovascular disease as an independent scientist. In addition, he has surrounded himself with a group of highly experienced Scientific Advisors that are leaders in engineering, optical imaging, vascular biology, and coronary stent design — Dr. Gary Tearney (MGH), Dr. Peter Libby (Brigham and Women's Hospital), and Dr. Elazer Edelman (Massachusetts Institute of Technology) — and will help guide him scientifically and in his career development as he grows to independence. Dr. Osborn's research proposal aims to investigate in vivo biological mechanisms underlying abnormal coronary stent healing, to better understand, predict, and prevent stent complications, using translatable intravascular molecular-structural imaging. The stent complications of restenosis (narrowing due to scar tissue growth) and thrombosis (occlusive blood clot) are major limitations of stent technology, and lead to tens-of- thousands of repeat invasive procedures and adverse cardiovascular events each year. His research aims will leverage a novel and highly translational catheter-based intravascular imaging system developed in Dr. Jaffer's laboratory that combines near-infrared fluorescence (NIRF) molecular imaging with optical coherence tomography (OCT) microstructural imaging. In Aim 1, we will investigate mechanisms of coronary stent restenosis in experimental subjects related to in vivo NIRF protease inflammatory activity, and whether intervention with the anti-inflammatory drug colchicine can decrease restenosis by modulating stent inflammation in vivo. In Aim 2, we will define the healing response of the newest FDA-approved stents with bioabsorbable polymer coatings, promoted as safer, rapidly healing stents, using intravascular NIRF-OCT molecular-structural imaging of fibrin and stent tissue coverage. The an... ## Key facts - **NIH application ID:** 9850622 - **Project number:** 5K08HL130465-04 - **Recipient organization:** BETH ISRAEL DEACONESS MEDICAL CENTER - **Principal Investigator:** Eric A Osborn - **Activity code:** K08 (R01, R21, SBIR, etc.) - **Funding institute:** NIH - **Fiscal year:** 2020 - **Award amount:** $164,376 - **Award type:** 5 - **Project period:** 2017-01-01 → 2021-12-31 ## Primary source NIH RePORTER: https://reporter.nih.gov/project-details/9850622 ## Citation > US National Institutes of Health, RePORTER application 9850622, Intravascular Molecular-Structural Imaging of Coronary Stent Pathobiology (5K08HL130465-04). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/9850622. Licensed CC0. --- *[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*